BioNTech to Buy CureVac for $1.25 Billion to Boost Cancer Arm
BioNTech SE agreed to buy former Covid vaccine rival CureVac NV for about $1.25 billion in an all-stock transaction that…
Tag: BioNTech
Stock Movers: BioNTech, Boeing, Nucor (Podcast)
Source: Bloomberg, 3:20 www.bloomberg.com #Stock #Movers #BioNTech #Boeing #Nucor #Podcast